Lexeo Therapeutics, Inc. Common Stock (LXEO)

Lexeo Therapeutics, Inc. Common Stock (LXEO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $217M; returns 1 day -3.1%, 1 week +6.1%, 1 year -68.9%.

Lexeo Therapeutics Inc. (LXEO) is a clinical-stage genetic medicine company focused on developing gene therapies for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease.

Groups LXEO belongs to

• Biotechnology
• Gene Therapy
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Rare Diseases
• Cardiovascular Therapies
• Alzheimer's Disease
• Precision Medicine
• Regenerative Medicine
• Neuroscience
• CNS Disorders
• Life Sciences

LXEO financial model: income statement, cash flow and balance sheet